USC partners with Autobahn Labs to accelerate drug discovery
New collaboration focuses on transforming academic research into innovative therapies for urgent medical conditions, including cancer and heart disease.
List view / Grid view
New collaboration focuses on transforming academic research into innovative therapies for urgent medical conditions, including cancer and heart disease.
The study’s findings could contribute to future therapeutic strategies to prevent chronic kidney disease.
The new technique could be adapted to produce a wide range of antibodies to combat chronic conditions like HIV.
Induced NPCs facilitate the creation of patient-specific organoid models and improve identification of nephron targeted drugs.
Using cortical organoids, researchers discovered that targeting KCNJ2 could reduce nerve cell death after TBI.
A new discovery from the University of Southern California (USC) on cancer metastasis has opened up new possibilities for combating the spread of this devastating disease.
A new platform, named Virtual Synthon Hierarchical Enumeration Screening, has been developed by researchers to efficiently discover drugs.
Researchers have developed kidney organoids that resemble the collecting duct system, using ureteric bud progenitor cells.
Using computer modelling, a team has shown that a molecular chaperone called GRP78 could be targeted by drugs in strategies to treat COVID-19.
Regulator genes and proteins have been identified on circulating tumour cells in mice which allow them to target other organs in the body.
Researchers have developed a polio vaccine that doesn't require refrigeration, meaning it could someday be used all over the world...
The human body’s blood stem cells produce approximately 10 billion new white blood cells – termed immune cells – every day. Scientists in the U.S. have now discovered that some blood stem cells pick up the slack should any others fail to achieve these levels.
Researchers in the US have undertaken meta-analysis studies to ascertain the optimum approach for doctors treating rare mixed phenotype acute leukaemia (MPAL). They found that a less-toxic regimen gives better results.
Scientists have discovered a molecule that enhances cartilage regeneration and decreases inflammation.
Researchers have developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognise and kill cancer cells.